Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism APLN inhibitors(apelin inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Phanes Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization Phanes Therapeutics, Inc.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular oedema | Preclinical | US | Phanes Therapeutics, Inc.Startup | - |
Dystrophy, Macular | Preclinical | US | Phanes Therapeutics, Inc.Startup | - |
Glioblastoma | Preclinical | US | Phanes Therapeutics, Inc.Startup | - |